rs752742151
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2
The NM_004208.4(AIFM1):c.452G>A(p.Arg151Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,210,520 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004208.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AIFM1 | NM_004208.4 | c.452G>A | p.Arg151Gln | missense_variant | 4/16 | ENST00000287295.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AIFM1 | ENST00000287295.8 | c.452G>A | p.Arg151Gln | missense_variant | 4/16 | 1 | NM_004208.4 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112268Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34426
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183336Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67790
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1098252Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 6AN XY: 363606
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112268Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34426
ClinVar
Submissions by phenotype
Severe X-linked mitochondrial encephalomyopathy Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Likely pathogenic, no assertion criteria provided | case-control | Biochemistry Laboratory of CDMU, Chengde Medical University | - | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31178897, 34416374, 32376792) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 24, 2016 | - - |
Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 13, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with AIFM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 214082). This variant is present in population databases (rs752742151, ExAC 0.01%). This sequence change replaces arginine with glutamine at codon 151 of the AIFM1 protein (p.Arg151Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at